Nasal Spray to Prevent Postpartum Depression
Treatments studied
Part of Mental health, Women’s health & pregnancy clinical trials.
This trial tests whether a dexmedetomidine nasal spray given during labor can help prevent postpartum depression after childbirth. If you are having a planned vaginal delivery with epidural pain relief, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are having a single baby (not twins or more).
- Your baby is head-down (cephalic presentation).
- You are healthy enough for epidural pain relief and planning to use it for vaginal delivery.
- You have no major heart, liver, kidney, or brain problems.
- You do not have a history of bipolar disorder, other mental health conditions, or suicidal thoughts.
- You do not have a history of drug or alcohol abuse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your expectations about pain relief during labor might affect your mood after giving birth. Researchers will follow you after delivery to see if there is a link between your hopes for pain management and the risk of postpartum depression.
This study tests if a nasal spray containing dexmedetomidine can prevent fever from developing during labor in women receiving epidural pain relief. The medicine helps keep body temperature normal while you are in labor.
This study tests whether a nasal spray containing two medications (esketamine and dexmedetomidine) can help prevent postpartum depression in pregnant women who show early signs of depression. Postpartum depression is common and can be serious, so this trial explores a new way to treat it right around the time of delivery.
This trial studies whether a specific numbing/comfort medicine (dexmedetomidine) injected into the wound area during a C-section can improve recovery or reduce symptoms after surgery. You may be able to take part if you are a low-risk pregnancy and meet safety requirements.
This trial tests a medicated mist (nebulized dexmedetomidine) given before a C-section under general anesthesia. It aims to prevent a dangerous spike in blood pressure during the breathing tube placement, which is common in severe preeclampsia.
This trial tests a nasal spray (dexmedetomidine) given before breast-conserving surgery to help you stay calm and comfortable while awake during the procedure. It aims to improve your recovery and waking experience after surgery.
Hear when a new Postpartum Depression (PPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.